Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 1 |
2022 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
DigiMir Test: Establishing a Novel Pipeline for MiR-371a Quantification Using Droplet Digital PCR in Liquid Biopsies From Testicular Germ Cell Tumor Patients.
Front Oncol. 2022 Jun 10;12:876732. doi: 10.3389/fonc.2022.876732. eCollection 2022.
Front Oncol. 2022.
PMID: 35756620
Free PMC article.
In this work, we provide a report of a ddPCR-based pipeline for the quantification of hsa-miR-371a-3p (the DigiMir pipeline) and compare it with two RT-qPCR protocols. ...Therefore, in this proof-of-concept investigation, we have shown that the DigiMir pipeli …
In this work, we provide a report of a ddPCR-based pipeline for the quantification of hsa-miR-371a-3p (the DigiMir pipe …
Pattern of expression of microRNA in patients with radiation induced bladder injury.
Nakamura K, Ohno T, Inamoto T, Takai T, Uchimoto T, Fukushima T, Nishimura K, Yano Y, Nishio K, Kinoshita S, Matsunaga T, Nakamori K, Tsutsumi T, Tsujino T, Uehara H, Komura K, Takahara K, Azuma H.
Nakamura K, et al.
Oncology. 2023 Dec 29. doi: 10.1159/000535993. Online ahead of print.
Oncology. 2023.
PMID: 38160665
RESULTS: Hsa-miR-130a, hsa-miR-200c, hsa-miR-141, and hsa-miR-96 were found to be highly expressed (>50 times) in patients with fibrotic bladder shrinkage (FBS) compared to those with intact bladder (IB) function. In patients with FBS, hsa-miR-6835, hsa-miR-4675, hsa- …
RESULTS: Hsa-miR-130a, hsa-miR-200c, hsa-miR-141, and hsa-miR-96 were found to be highly expressed (>50 times) in patients with fibrotic …
Item in Clipboard
Investigation of differentially expressed gene profile for cisplatin-treated lung cancer patients.
Gu S, Wu Q, Li Y, Jia W, Zhang D, Jiao L, Zhang Y.
Gu S, et al.
Anticancer Drugs. 2021 Sep 1;32(8):875-881. doi: 10.1097/CAD.0000000000001075.
Anticancer Drugs. 2021.
PMID: 33967201
With further instigation, five miRNAs (hsa-miR-548ah, hsa-miR-466, hsa-miR-552, hsa-miR-371a, and hsa-miR-4445) were suggested to be the key targets in the cisplatin-treated patients. ...
With further instigation, five miRNAs (hsa-miR-548ah, hsa-miR-466, hsa-miR-552, hsa-miR-371a, and hsa-miR-4445) were su …
Item in Clipboard
Cite
Cite